Baldwin Brothers LLC Novo Nordisk A S Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Baldwin Brothers LLC holds 55,255 shares of NVO stock, worth $5.72 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

55,255

Previous 48,788 13.26%

Holding current value

$5.72 Million

Previous $6.96 Million 5.51%

% of portfolio

0.46%

Previous 0.55%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$119.07 - $145.42 $770,025 - $940,431	6,467 Added 13.26%	55,255 $6.58 Million
Q2 2024 Jul 12, 2024	SELL	$122.71 - $146.91 $13,375 - $16,013	-109 Reduced 0.22%	48,788 $6.96 Million
Q1 2024 Apr 12, 2024	SELL	$102.11 - $135.92 $124,063 - $165,142	-1,215 Reduced 2.42%	48,897 $6.28 Million
Q4 2023 Jan 08, 2024	SELL	$87.78 - $105.45 $351,295 - $422,010	-4,002 Reduced 7.4%	50,112 $5.18 Million
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $2.46 Million - $5.4 Million	27,062 Added 100.04%	54,114 $4.92 Million
Q2 2023 Jul 14, 2023	SELL	$155.98 - $172.65 $19,029 - $21,063	-122 Reduced 0.45%	27,052 $4.38 Million
Q1 2023 Apr 21, 2023	SELL	$132.34 - $159.14 $10,057 - $12,094	-76 Reduced 0.28%	27,174 $4.32 Million
Q4 2022 Jan 27, 2023	BUY	$102.55 - $135.33 $2.52 Million - $3.32 Million	24,531 Added 902.21%	27,250 $0
Q3 2022 Oct 14, 2022	SELL	$95.28 - $116.93 $2,382 - $2,923	-25 Reduced 0.91%	2,719 $271,000
Q2 2022 Jul 18, 2022	SELL	$103.24 - $121.81 $4,026 - $4,750	-39 Reduced 1.4%	2,744 $306,000
Q1 2022 Apr 13, 2022	SELL	$93.1 - $112.54 $10,427 - $12,604	-112 Reduced 3.87%	2,783 $309,000
Q4 2021 Jan 14, 2022	BUY	$95.88 - $117.08 $14,765 - $18,030	154 Added 5.62%	2,895 $324,000
Q3 2021 Oct 27, 2021	SELL	$84.42 - $106.62 $3,967 - $5,011	-47 Reduced 1.69%	2,741 $263,000
Q2 2021 Jul 30, 2021	SELL	$67.66 - $84.76 $6,360 - $7,967	-94 Reduced 3.26%	2,788 $234,000
Q1 2021 Apr 08, 2021	SELL	$67.06 - $75.82 $33,194 - $37,530	-495 Reduced 14.66%	2,882 $194,000
Q4 2020 Jan 12, 2021	SELL	$63.89 - $73.8 $5,111 - $5,904	-80 Reduced 2.31%	3,377 $236,000
Q3 2020 Oct 16, 2020	SELL	$63.69 - $70.22 $764 - $842	-12 Reduced 0.35%	3,457 $240,000
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $13,171 - $15,286	-225 Reduced 6.09%	3,469 $227,000
Q1 2020 Apr 15, 2020	SELL	$49.46 - $64.78 $31,407 - $41,135	-635 Reduced 14.67%	3,694 $222,000
Q4 2019 Jan 29, 2020	BUY	$49.86 - $58.26 $50,458 - $58,959	1,012 Added 30.51%	4,329 $251,000
Q3 2019 Oct 10, 2019	SELL	$47.54 - $53.43 $628,003 - $705,810	-13,210 Reduced 79.93%	3,317 $171,000
Q2 2019 Jul 19, 2019	SELL	$46.79 - $52.47 $174,105 - $195,240	-3,721 Reduced 18.38%	16,527 $844,000
Q3 2018 Oct 26, 2018	SELL	$46.76 - $51.24 $64,201 - $70,352	-1,373 Reduced 6.35%	20,248 $954,000
Q1 2018 Apr 16, 2018	SELL	$48.49 - $58.14 $9,698 - $11,628	-200 Reduced 0.92%	21,621 $1.07 Million
Q4 2017 Jan 24, 2018	BUY	$47.53 - $53.73 $35,362 - $39,975	744 Added 3.53%	21,821 $1.17 Million
Q3 2017 Oct 26, 2017	BUY	$41.15 - $49.22 $867,318 - $1.04 Million	21,077	21,077 $1.02 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Novo Nordisk A S Transaction History